DAVID ROY BANGSBERG

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Potential for false positive HIV test results with the serial rapid HIV testing algorithm
    Steven Baveewo
    Department of Medicine, Makerere University School of Medicine, Kampala, Uganda
    BMC Res Notes 5:154. 2012
  2. ncbi Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009
    Elvin H Geng
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, San Francisco, CA, USA
    J Int AIDS Soc 14:46. 2011
  3. ncbi A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people
    David R Bangsberg
    Massachusetts General Hospital Center for Global Health, Ragon Institute of MGH, MIT, and Harvard, Harvard Medical School, Boston, USA
    AIDS 24:2835-40. 2010
  4. ncbi A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV
    Alexander C Tsai
    Langley Porter Psychiatric Institute, University of California at San Francisco, USA
    Arch Gen Psychiatry 67:1282-90. 2010

Research Grants

  1. HIV Treatment in the homeless: a prospective study
    David Bangsberg; Fiscal Year: 2004
  2. Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
    DAVID ROY BANGSBERG; Fiscal Year: 2010
  3. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2009
  4. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2006
  5. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2004

Collaborators

  • Steven Baveewo
  • Elvin H Geng
  • Alexander C Tsai
  • Rhoda K Wanyenze
  • Robin Fatch
  • Moses R Kamya
  • Harriet Mayanja-Kizza
  • Judith A Hahn
  • Thomas Coates
  • Jeffrey N Martin
  • Paula Braitstein
  • Lameck O Diero
  • Pius Okong
  • Batya Elul
  • Juliana A Otieno
  • Geofrey R Somi
  • Mwebesa B Bwana
  • Denis Nash
  • Craig R Cohen
  • Peter W Hunt
  • Beverly S Musick
  • Philippa J Easterbrook
  • Kara Wools-Kaloustian
  • Sylvester Kimaiyo
  • Deo Wabwire
  • Constantin T Yiannoutsos
  • Margot B Kushel
  • Sheri D Weiser
  • Kathleen Ragland
  • Maya L Petersen

Detail Information

Publications4

  1. ncbi Potential for false positive HIV test results with the serial rapid HIV testing algorithm
    Steven Baveewo
    Department of Medicine, Makerere University School of Medicine, Kampala, Uganda
    BMC Res Notes 5:154. 2012
    ..We conducted further testing on this subgroup of samples using qualitative DNA PCR to assess the potential for false positive tests in this situation...
  2. ncbi Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009
    Elvin H Geng
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, San Francisco, CA, USA
    J Int AIDS Soc 14:46. 2011
    ..Regionally representative socio-demographic, laboratory and clinical characteristics of patients accessing ART over time and across sites have not been well described...
  3. ncbi A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people
    David R Bangsberg
    Massachusetts General Hospital Center for Global Health, Ragon Institute of MGH, MIT, and Harvard, Harvard Medical School, Boston, USA
    AIDS 24:2835-40. 2010
    ..The virologic effectiveness of this STR in a potentially nonadherent population remains a concern, given the rapid selection of drug resistance seen with these drugs...
  4. ncbi A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV
    Alexander C Tsai
    Langley Porter Psychiatric Institute, University of California at San Francisco, USA
    Arch Gen Psychiatry 67:1282-90. 2010
    ..Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial...

Research Grants18

  1. HIV Treatment in the homeless: a prospective study
    David Bangsberg; Fiscal Year: 2004
    ..The proposed research will assist in the development of both behavioral and therapeutic strategies to extend treatment and reduce the risk of drug resistance in this important population. ..
  2. Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
    DAVID ROY BANGSBERG; Fiscal Year: 2010
    ..Thus, this study has the potential to transform HIV practice in both resource-limited and resource-rich settings, including the US. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page ..
  3. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2009
    ..To better guide therapy in both settings, these studies will further our understanding of drug resistance, including its causes, its extent and the role it plays in disease progression and death. ..
  4. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2006
    ..Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect. ..
  5. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2004
    ..We will examine five primary aims, including depression treatment, adherence to antiretroviral therapy, duration of sustained antiretroviral treatment, initiation of treatment, and viral suppression. ..